Navigation Links
VirtualScopics to Present at Two Upcoming Investor Conferences
Date:11/3/2008

ROCHESTER, N.Y., Nov. 3 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSCP), a leading provider of quantitative imaging for clinical trials, announced today that Ms. Molly Henderson, the company's chief business and financial officer, will be presenting a corporate and financial overview at two upcoming investor conferences. Ms. Henderson will be presenting on November 6, 2008 at the Western New York Investors Conference in Buffalo, New York. Additionally, Ms. Henderson will be presenting at the Rodman & Renshaw Annual Global Investment Conference at The New York Palace Hotel in New York City.

Ms. Henderson's presentation at the Rodman & Renshaw Annual Global Investment Conference is scheduled for November 12, 2008 at 2:25 pm EST. A live webcast of the presentation will be available in the Investor Relations section of the company's website, http://www.virtualscopics.com .

About VirtualScopics, Inc.

VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster. For more information about VirtualScopics, visit http://www.virtualscopics.com .

Forward-Looking Statements

The statements contained in this press rel
'/>"/>

SOURCE VirtualScopics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. VirtualScopics Schedules Third Quarter 2008 Earnings Announcement
2. VirtualScopics Reports Second Quarter 2008 Results
3. VirtualScopics Receives NASDAQ Delisting Notice; Company Files Appeal to Stay Delisting
4. VirtualScopics Backlog Exceeds a Record $20 Million
5. VirtualScopics Announces $4.35 Million Private Placement
6. Tibotec presents interim findings for TMC435, an investigational genotype 1 hepatitis C treatment
7. BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference
8. LCA-Vision to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
9. NMB's Fans and Blowers to be Represented in Canada by CST-Arwin
10. The Ensign Group to Present at the Oppenheimer 19th Annual Healthcare Conference
11. Satellite Healthcare Will Present at the American Society of Nephrology's Renal Week – Booth 527 : November 4-9, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...t;Preventing and Healing AIDS Through Our Inner Ph...S is a result of multiple, repeated and chronic ex...essor agents, which can be either chemical, physic... Oakland, CA (PRWEB) November...ogists, physicians, chemists and other scientists ...
(Date:11/8/2009)...pharmaceuticals to be available at the Company&rsq... Toronto, ON (PRWEB) November 8, 2009... Biopharma Inc. today announced that the Company h...ical grade freeze dryer and expects to make commer...e for contract manufacturing of biopharmaceuticals...
(Date:11/8/2009)...n the Western District of Pennsylvania award a Fay... for a medical malpractice case. Attorneys Thomas...s E. Crenney and Associates, LLC handled the case ...gainst the Uniontown Hospital. The woman had to h...ge 18. , Pittsburgh, PA(P...
(Date:11/8/2009)...s won," said Dr. Charmaine Yoest. ,, WASHINGTO...240-194, the Stupak-Ellsworth-Pitts-Kaptur-Dahlkem...mandates and funding in HR 3962 passed on the Hous...esident and CEO Dr. Charmaine Yoest said, "The pas...fe Americans across this country who have flooded ...
(Date:11/8/2009)...e/ -- USAction this evening hailed passage of the ... make health care more affordable for consumers, h...ccess to health care for millions of Americans thr...and Harry Truman would be proud," said USAction Pr...mong our country,s proudest achievements. Today we...
Breaking Medicine News(10 mins):Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2
...ve Website For Physically Able 50+ Adults To Promo...tyle , , CABOT, Vt., May 18 If you are age 50+,...ey of health and fitness that begins in the great ... Silver Fox, log on to Cabot,s Vermont To Fabulou...
...rating Officer Promotion , , FREMONT, Calif., May...: WGBS), a leading developer of state-of-the-art g...ppointments, naming Robert J. Hariri, M.D., Ph.D.,...life science industry experience, Drs. Hariri and ...
... support program designed to improve treatment out...illers or heroin, from Reckitt Benckiser Pharmaceu...ckiser Pharmaceuticals has launched Here to Help(...oxone HCl dihydrate [2 mg/0.5 mg and 8 mg/2 mg]) C...
...e Chance to Celebrate Dad and Give Back To A Worth...e 21, children will honor father figures in their ... wire service, is helping them score a home run w...o help raise awareness for prostate cancer and rai...
... IRVINE, Calif., May 18 /PRNewswire-FirstCall/ ...02) and IDM Pharma, Inc. (Nasdaq: IDMI ) today a...lly-owned subsidiary of Takeda (Takeda America), a... wholly-owned subsidiary to effect that transactio...
...th supplements product, helps slow and repair some...ns as we age , , MIAMI, May 18 RevGenetics annou...based telomere health supplements , Astral ...represent biomarkers of human aging and disease."*...
Other Medicine News:Health News:Cabot Creamery Cooperative's 'Vermont to Vegas' Online Health and Fitness Challenge is a Virtual Blast 2Health News:Cabot Creamery Cooperative's 'Vermont to Vegas' Online Health and Fitness Challenge is a Virtual Blast 3Health News:WaferGen Appoints Seasoned Industry Executives to Board of Directors and Scientific Advisory Board 2Health News:WaferGen Appoints Seasoned Industry Executives to Board of Directors and Scientific Advisory Board 3Health News:WaferGen Appoints Seasoned Industry Executives to Board of Directors and Scientific Advisory Board 4Health News:WaferGen Appoints Seasoned Industry Executives to Board of Directors and Scientific Advisory Board 5Health News:Here to Help(TM): Unique Program Combines Direct Personal Assistance With Web-Based Resources to Improve Opioid Dependence Treatment Outcomes 2Health News:Here to Help(TM): Unique Program Combines Direct Personal Assistance With Web-Based Resources to Improve Opioid Dependence Treatment Outcomes 3Health News:Here to Help(TM): Unique Program Combines Direct Personal Assistance With Web-Based Resources to Improve Opioid Dependence Treatment Outcomes 4Health News:Here to Help(TM): Unique Program Combines Direct Personal Assistance With Web-Based Resources to Improve Opioid Dependence Treatment Outcomes 5Health News:Teleflora Hits it out of the Park With Flower Gifts for Father's Day 2Health News:Teleflora Hits it out of the Park With Flower Gifts for Father's Day 3Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 2Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 3Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 4Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 5Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 6Health News:RevGenetics Releases Its New Science-Based Telomere Health Supplement Formulation for DNA and Chromosome Health 2Health News:RevGenetics Releases Its New Science-Based Telomere Health Supplement Formulation for DNA and Chromosome Health 3Health News:RevGenetics Releases Its New Science-Based Telomere Health Supplement Formulation for DNA and Chromosome Health 4
(Date:11/6/2009)...ON, Ky., Nov. 6 Virtual ...I) confirmed today that the previously confirmed L...sets to Wound Management Technologies, Inc (WNDM) ...ctors and shareholders of VHGI. ,, Sharehold...l stock dividend, royalty stream and cash realized...
(Date:11/6/2009)...H TRIANGLE PARK, N.C., Nov. 6 Chim...orally-available antiviral therapeutics to address...he development of the company,s lead antiviral com...HO) and the Global Health Security Initiative (GHS...ing developed for the treatment of smallpox, as we...
(Date:11/6/2009)...GO, Nov. 6 California American Wat..."No Drugs Down the Drain" week for its San Diego C...sponsored by public and private agencies alike tow...pollution in our source water supplies. ,, Cali... are encouraged to drop off expired or unwanted ph...
Breaking Medicine Technology:OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3California American Water Celebrates 'No Drugs Down the Drain' Week in San Diego 2Meat Dairy Wont Up Odds for Breast Cancer 55638 1Meat Dairy Wont Up Odds for Breast Cancer 55638 2Meat Dairy Wont Up Odds for Breast Cancer 55638 3WDIV TV Blue Cross Blue Shield of Michigan and The Parade Company Help Launch The Biggest Loser 3A Detroit Edition 55634 1WDIV TV Blue Cross Blue Shield of Michigan and The Parade Company Help Launch The Biggest Loser 3A Detroit Edition 55634 2Acoustic tweezers can position tiny objects 9729 1Acoustic tweezers can position tiny objects 9729 2Acoustic tweezers can position tiny objects 9729 3
... study, called POLI 1 -, BOSTON, Nov. 2 R1626, o...c hepatitis C virus (HCV) infection, has,shown pro...n with,PEGASYS(R) (peginterferon alfa-2a) and COPE...esented at the American Association for the Study ...n Boston, Nov. 2-6. After four,weeks of treatment ...
...mprove,significantly the safety and well-being of ...ency medical information service, has joined,the A...,s research and,support, to offer MedicAlert(R) + ...illion Americans living with Alzheimer,s and almos...mer,s or another dementia. (Photo: http://www.ne...
Other Medicine Technology:Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 2Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 3Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 4Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 5Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 6Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 7MedicAlert Foundation Joins The Alzheimer's Association to Offer MedicAlert(R) + Alzheimer's Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies 2MedicAlert Foundation Joins The Alzheimer's Association to Offer MedicAlert(R) + Alzheimer's Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies 3
Maverick Over-The-Wire 9 mm Catheter
CT100 Contact Tonometer
...ASURABLE ROI - Our networked solutions are deliver...cardiology. Never purchase software upgrades again...s to meet the ever-changing needs of your healthca...iology departments have a mix of old and new equip...
...X for Cardiology is the first digital solution des...us modalities both within and outside cardiology. ...chival solutions, Agfas combined expertise in both...r customers to work the way they want, wherever th...
Medicine Products: